Background variables for the patients with invasive bladder cancer suitable for bladder-preserving therapy

Japanese Journal of Clinical Oncology

Volumn 37, Issue 11, 2007, Pages 852-857

  Miyanaga, Naoto ^a   Akaza, Hideyuki ^a   Hinotsu, Shiro ^a   Joraku, Akira ^a   Oikawa, Takehiro ^a   Sekido, Noritoshi ^a   Kawai, Koji ^a   Shimazui, Toru ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Bladder preservation; Chemotherapy; Invasive bladder cancer; Radiotherapy

Indexed keywords

CISPLATIN; METHOTREXATE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER DISEASE; BLADDER FUNCTION; BLADDER IRRITATION; BLADDER SURGERY; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; CYSTECTOMY; DATA ANALYSIS; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; PATIENT SELECTION; PROTON THERAPY; SCIATIC NEUROPATHY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK ASSESSMENT; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 37149007272     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym129     Document Type: Article

References (24)

1. Sternberg CN, Arena MG, Calabresi F, De Carli P, Platania A, Zeuli M, et al. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder. Cancer 1993;72:1975-82.
2. Matsui Y, Nishiyama K Watanabe J, Teramukai S, Ono Y, Ohshima S, et al. The current status of perioperative chemotherapy for invasive bladder cancer: A multiinstitutional retrospective study in Japan. Int J Clincm Oncol 2005;10:133-8.
3. Akaza H. Advances in chemotherapy of invasive bladder cancer. Curr Opin Urol 2000;10:453-7.
4. Tsukamoto T, Kitamura H, Takahashi A, Masumori N. Treatment of invasive bladder cancer: Lessons.from the past and perspective for the future. Jpn J Clin Oncol 2004;34:295-306.
5. Miyanaga N, Akaza H, Okumura T, Sekido N, Kawai K, Shimazui T, et al. A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: A prospective study. Int J Urol 2000;7:41-8.
6. Tsujii H, Akaza H, Ohtani M, Miyanaga N, Shimazoi T, Uchida K, et al. Preliminary results of bladder-preserving therapy with definitive radiotherapy and intruarterial infusion of chemotherapy. Strahlenther Onkol 1994;170:531-7.
7. Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, et al. Proton beam therapy for invasive bladder cancer: A prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Int J Radiat Oncol Biol Phys 2006;64:1371-9.
8. Shipley WU, Kaufman DS, Heney Nm, Althausen AF, Zietman AL. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy. J Urol 1999;162:445-51.
9. Rodel C, Grabenbauer GG, Kuhn R, Papadopoulos T, Dunst J, Meyer M, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 2002;20:3061-71.
10. Eapen L, Stewart D, Collins J, Peterson R. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. J Urol 2004;172:1276-80.
11. Mokarim A, Uetani M, Hayashi N, Sakamoto I, Minami K, Ogawa Y, et al. Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma. Cancer 1997;80:1776-85.
12. Sumiyoshi Y, Yokota K, Akiyama M, Inoue Y, Yoneda. F, Tsujimura H, et al. Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder. J Urol 1994; 152(2 Pt 1):362-6.
13. Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, et al, Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: A survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 2004;45:176-81.
14. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666-75.
15. Sekido N, Miyanaga N, Kikuchi K, Takeshima H, Akaza H. Lower urinary tract function after intra-arterial chemotherapy with concurrent pelvic radiotherapy for invasive bladder cancer. Jpn J Clin Oncol 1999;29:479-84.
16. Miyanaga N, Akaza H, Shinohara N, Koyanagi T, Tsujino S, Miki M, et al. Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer. Nippon Hinyokika Gakkai Zasshi 1999;90:445-53.
17. Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM. Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates - the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 2005;15:36-41.
18. Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallade S, Chuang V, et al. Clinical pharmacology of intraarterial cis-diammmedichlomplatinum(II). Cancer Res 1983;43:917-20.
19. Akaza H. Developing therapies for advanced bladder cancer. Expert Opin Investig Drugs 2002;11:109-15.
20. Gospodarowicz M. Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence? J Clin Oncol 2002;20:3048-50.
21. O'Donnell MA, Lilli K., Leopold C. Contemporary profile of superficial bladder cancer as revealed from an open-entry national multicenter study. J Urol 2004;171(Suppl 4):74.
22. Cancer Registration Committee of the Japanese Urological Association. The report of clinical statistical studies on registered bladder cancer patients in Japan. Nippon Hinyokika Gakkai Zasshi 2006;97(Suppl 3):1-31.
23. Dunst J, Rodel C, Zietman A, Schrott KM, Sauer R, Shipley WU. Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol 2001;20:24-32.
24. Weiss C, Rodel F, Wolf I, Papadopoulos T, Engehausen DG, Schrott KM, et al. Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome? Strahlenther Onkol 2005;181:213-22.